TSX:BHC (Bausch Health Companies Inc.)
About BHC
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors.
Financial Market Data copyright © 2026
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Profiles by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Financials by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2026
QuoteMedia. Data delayed 15 minutes unless otherwise
indicated (view
delay times for all exchanges).
RT=Real-Time, EOD=End of Day,
PD=Previous Day. Market
Data powered by QuoteMedia.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Share Information by Morningstar.
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Dividends by EDI/Mergent (USA) and TSX (CDN).
Terms of Use.
Financial Market Data copyright © 2022
QuoteMedia.
Market Data powered by
QuoteMedia. Earnings and Analyst Ratings by Zacks.
Earnings Events by Wall Street Horizon.
Terms of Use.
Bausch Health Companies Inc. (TSX: BHC) Latest News
Investing
Valeant Pharmaceuticals Intl Inc.: We Are Still in the Early Innings
Investing
Has Valeant Pharmaceuticals Intl Inc. Changed?
Investing
Valeant Pharmaceuticals Intl Inc.: Another Day, Another Controversy
Stocks for Beginners
Why New Investors Should Stop Hoping for Quick Gains
Investing
Valeant Pharmaceuticals Intl Inc.: If You Believe Management, it’s a Screaming Buy
Investing
Valeant Pharmaceuticals Intl Inc.: the 3 Biggest Takeaways From its Latest Conference Call
Investing
Valeant Pharmaceuticals Intl Inc.: Why its Pricing Strategy Is Immoral and Unsustainable
Investing
Why Are Shares of Valeant Pharmaceuticals Intl Inc. Plunging This Time?
Investing
The 3 Biggest Threats Facing Valeant Pharmaceuticals Intl Inc.
Investing
Valeant Pharmaceuticals Intl Inc. Has Lost $100 Billion in Value Since August. Is it Going to $0?
Investing
Why Bill Ackman Thinks Valeant Pharmaceuticals Intl Inc. Will Quadruple in 3 Years